LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,068,368,938 | -9.2% | 15,905,448 | -6.7% | 0.09% | -7.1% |
| Q2 2023 | $1,176,650,727 | -25.6% | 17,045,498 | -48.0% | 0.10% | +37.5% |
| Q1 2023 | $1,581,102,650 | +109.2% | 32,789,354 | +116.6% | 0.07% | -4.0% |
| Q4 2022 | $755,867,574 | +47.3% | 15,141,578 | +20.4% | 0.08% | +38.9% |
| Q3 2022 | $513,183,000 | +40.0% | 12,578,033 | +88.8% | 0.05% | +45.9% |
| Q2 2022 | $366,505,000 | +315.9% | 6,663,704 | +174.8% | 0.04% | +428.6% |
| Q1 2022 | $88,113,000 | +133.0% | 2,424,663 | +198.8% | 0.01% | +133.3% |
| Q4 2021 | $37,824,000 | +16.5% | 811,508 | +26.4% | 0.00% | 0.0% |
| Q3 2021 | $32,470,000 | +2037.6% | 642,200 | +1636.0% | 0.00% | – |
| Q2 2021 | $1,519,000 | +41.4% | 36,994 | 0.0% | 0.00% | – |
| Q1 2021 | $1,074,000 | +558.9% | 36,994 | +538.4% | 0.00% | – |
| Q4 2020 | $163,000 | -98.1% | 5,795 | -98.0% | 0.00% | -100.0% |
| Q3 2020 | $8,733,000 | -37.5% | 282,896 | -13.8% | 0.00% | -50.0% |
| Q2 2020 | $13,965,000 | – | 328,103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |